On Friday, Eli Lilly unveiled…
On Friday, Eli Lilly unveiled designs on a new, $3.5 [...]
Amgen has terminated its…
Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking [...]
Some officials in the Trump…
Some officials in the Trump administration are at odds with [...]
The ink was barely dry on…
The ink was barely dry on AstraZeneca’s announcement of a [...]
Moderna has out-licensed a rare…
Moderna has out-licensed a rare disease drug candidate to Recordati, [...]
The German CDMO devoted 480…
The German CDMO devoted 480 million euros ($574.3 million) to [...]
Cardiff is churning its leadership…
Cardiff is churning its leadership team as the biotech advances [...]
AI-fueled Formation Bio has inked…
AI-fueled Formation Bio has inked another licensing deal for a [...]
A few months after sending an…
A few months after sending an untitled letter to ARS [...]
Amid mounting concerns about the…
Amid mounting concerns about the state of vaccine policy in [...]